Healthcare Services

IVD Raw Materials Market Revenue Anticipated To Reach $43.76 Billion By 2030 With 9.8% CAGR

June 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Will Be The Estimated Market Size Of The IVD Raw Materials Market By 2030?

The ivd raw materials market has demonstrated substantial expansion in recent years. This market is projected to expand from $27.47 billion in 2025 to $30.16 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.8%. Historically, this growth was propelled by factors such as the increase in clinical diagnostic testing volumes, the growing acceptance of immunoassays, the broadening of molecular diagnostics, a heightened demand for early disease detection, and the established application of enzymes and antibodies within ivd kits.

The ivd raw materials market is projected to experience robust expansion in the coming years, set to reach $43.76 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.8%. Factors driving this growth during the forecast period include the increasing incidence of chronic and infectious diseases, greater investment in precision diagnostics, the expansion of point-of-care testing, burgeoning biopharmaceutical R&D efforts, and a growing need for tailored ivd raw materials. Key trends anticipated for this period encompass a heightened demand for high-purity diagnostic reagents, the increasing embrace of recombinant antibodies and proteins, broader application of molecular diagnostics raw materials, a stronger emphasis on quality and batch consistency, and the diversification of supply chains for essential ivd inputs.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24270&type=smp

What Market Drivers Are Helping Shape The IVD Raw Materials Market Expansion?

The future expansion of the IVD raw materials market is anticipated to be fueled by the rising occurrence of infectious diseases. These diseases are health conditions stemming from detrimental microorganisms capable of transmission between individuals or organisms. This growing incidence of infectious diseases is linked to swift urbanization, a factor that exacerbates their spread through higher population concentrations and by placing pressure on sanitation and healthcare systems. IVD raw materials are vital in confronting infectious diseases, as they facilitate the creation of precise diagnostic tools essential for prompt identification and efficient management of these conditions. For example, data from March 2024, provided by the Centers for Disease Control and Prevention, a US-based government agency, revealed an escalation in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, marking an increase of 1,295 cases. Consequently, the expanding occurrence of infectious diseases is a primary catalyst for the development of the IVD raw materials market.

How Is Segment Classification Applied In The IVD Raw Materials Market?

The ivd raw materials market covered in this report is segmented –

1) By Product: Antibodies, Antigens, Enzymes, Proteins, Biological Buffers

2) By Technology: Molecular Diagnostics, Clinical Chemistry, Immunochemistry

3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations

Subsegments:

1) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies

2) By Antigens: Recombinant Antigens, Native Antigens, Synthetic Antigens

3) By Enzymes: Polymerases, Reverse Transcriptases, Oxidases

4) By Proteins: Carrier Proteins, Blocking Proteins, Recombinant Proteins

5) By Biological Buffers: Tris Buffers, HEPES Buffers, Phosphate Buffers

What Trends Are Shaping The IVD Raw Materials Market Structure?

Companies operating within the IVD raw materials market are directing their efforts towards developing advanced solutions, including IVD manufacturing facilities, with the aim of strengthening regional diagnostic capabilities and supporting healthcare self-sufficiency. An IVD manufacturing facility is a specialized establishment where devices and equipment utilized for diagnosing diseases and conditions through laboratory testing of samples outside the human body are designed, produced, and subjected to quality and compliance testing. As an illustration, in January 2024, Colexa Biosensor Limited, a health technology company based in Nigeria, partnered with Codix Pharma Limited, a Nigerian pharmaceutical manufacturing company, to launch Sub-Saharan Africa’s first in vitro diagnostics (IVD) manufacturing facility in Lagos. This facility, responsible for producing the onpoint blood glucose meter and strips, represents a significant milestone in Africa’s healthcare industry, specifically designed to address the rising diabetes prevalence and improve diagnostic access. The facility possesses an annual production capacity of 3.6 million packs, with the capacity for expansion to 10.8 million packs, initially prioritizing the fulfillment of demands across West Africa.

Which Companies Form The Competitive Landscape Of The IVD Raw Materials Market?

Major companies operating in the ivd raw materials market are Merck KGaA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., LGC Limited, Neogen Corporation, MP Biomedicals, CUSABIO Technology, Fujirebio, Fapon Biotech, ABclonal Technology, Creative Diagnostics, AIVD Biotech Inc., OPERON, Beijing Diagreat Biotechnology Co. Ltd., Biosynth, Aalto Bio Reagents, Angstrom Biotech, Eximio Biotech, Glentham Life Sciences Limited, OYC Americas Inc., NOVA Biologics Inc., Sino Biological Inc., ACROBiosystems, ProSpec-Tany TechnoGene Ltd.

Access The Complete IVD Raw Materials Market Report:

https://www.thebusinessresearchcompany.com/report/ivd-raw-materials-global-market-report

Which Region Accounts For The Highest Share Of The IVD Raw Materials Market?

North America was the largest region in the IVD raw materials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ivd raw materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access IVD Raw Materials Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=24270&type=smp

Browse Through More Reports Similar to the Global IVD Raw Materials Market 2026, By The Business Research Company

Medical Engineered Materials Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-engineered-materials-global-market-report

International Wholesale Voice Carrier Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/international-wholesale-voice-carrier-global-market-report

Messenger Ribonucleic Acid Mrna Synthesis Raw Materials Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/messenger-ribonucleic-acid-mrna-synthesis-raw-materials-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795